Friday, April 11, 2014
The "Heartbleed Bug" has been in the news a lot lately, and for good reason. It's a security vulnerability in some versions of OpenSSL that allows the theft of information that is protected, under normal conditions, by the SSL/TLS encryption used to secure the Internet. It's estimated that this has impacted about 30% of all websites. That's a lot of websites.
The good news for PharmGKB users is that our services were not affected by the bug. You do not have to change your password on PharmGKB.
If you're looking for a simple explanation of the problem, xkcd has the most concise one I've seen to date:
We have published the
PharmGKB summary: very important pharmacogene information for SLC22A1 in the Pharmacogenetics and Genomics Journal.
Find out more...
View our SLC22A1 VIP on PharmGKB.
Read our new publication:
PharmGKB summary: very important pharmacogene information for SLC22A1
Goswami S, Gong L, Giacomini K, Altman RB, Klein TE.
Pharmacogenet Genomics. 2014 Mar 27. [Epub ahead of print]
View all VIPs on PharmGKB.
Thursday, April 10, 2014
Dr. Altman's year in review is meant as an overview for trends and publications for the previous year and to speculate about what opportunities might lie in the year ahead. He presented 32 publications (and 10 "shout outs") focused on translational bioinformatics in human biology.
The publications were organized into 8 topic areas:
- Clinical genomics
- Genetic basis of disease
- Emerging data sources
- Scientific process
- Odds & Ends
Sunday, April 6, 2014
On Monday 7th April, in a talk and poster presentation they will outline the PharmGKB curation process: how we curate PGx literature and interpret this for the clinic in the form of our Clinical Annotations.
The conference will cover five main curation topics; clinical annotations, data integration and sharing, systems biology, functional annotations and microbial informatics.
Wednesday, March 26, 2014
Dr. Whirl-Carrillo joined PharmGKB in 2002 as the project's first Scientific Curator. After briefly leaving PharmGKB to join the DTC genotyping start-up 23andMe, she returned in 2009 as the Assistant Director.
We congratulate Michelle on her achievement.